Why the study?
Does sublingual nitroglycerin improve left ventricular ejection fraction in patients with ischemic heart disease?
Population
27 patients with ischemic heart disease
Design
Cohort
Follow-up
20 to 25 minutes
Authors
Loading...
Greater EF response in normal vs akinetic segments may guide acute use; leaves open confirmation in randomized ischemic cohorts.
Does sublingual nitroglycerin improve left ventricular ejection fraction in patients with ischemic heart disease?
Sublingual nitroglycerin acutely improves left ventricular ejection fraction in patients with ischemic heart disease, with the greatest improvement observed in those with normal baseline contraction.
Hayashi et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: